A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
February 28th, 2019
12.7K views
An approach is described for real-time detection of the innate immune response to cutaneous wounding and Staphylococcus aureus infection of mice. By comparing LysM-EGFP mice (which possess fluorescent neutrophils) with a LysM-EGFP crossbred immunodeficient mouse strain, we advance our understanding of infection and the development of approaches to combat infection.
Overview
This study presents a method for real-time monitoring of the innate immune response to skin wounds and Staphylococcus aureus infections in mice. By utilizing LysM-EGFP mice with fluorescent neutrophils, the research enhances our understanding of infection dynamics and potential treatment strategies.
Key Study Components
Area of Science
- Immunology
- Infectious Diseases
- Mouse Models
Background
- Understanding the immune response to bacterial infections is crucial for developing effective treatments.
- Staphylococcus aureus is a common pathogen that poses significant health risks.
- Real-time monitoring techniques can provide valuable insights into infection mechanisms.
- Fluorescent labeling of neutrophils allows for detailed observation of immune responses.
Purpose of Study
- To investigate the innate immune response to cutaneous wounding.
- To assess the response to Staphylococcus aureus infection in a live mouse model.
- To compare immune responses in different mouse strains.
Methods Used
- Real-time imaging of neutrophil responses using LysM-EGFP mice.
- Inoculation of skin wounds with Staphylococcus aureus.
- Monitoring bacterial burden and neutrophil activity simultaneously.
- Longitudinal measurements throughout the duration of infection.
Main Results
- Real-time detection of neutrophil responses was successfully achieved.
- Differences in immune responses were observed between mouse strains.
- The technique allowed for the assessment of bacterial persistence.
- Insights gained could inform treatment strategies for infections.
Conclusions
- This approach enhances understanding of the immune response to infections.
- Real-time monitoring can lead to improved treatment strategies.
- Future research may build on these findings to combat bacterial infections.
Frequently Asked Questions
What is the significance of using LysM-EGFP mice?
LysM-EGFP mice allow for visualization of neutrophils, providing insights into immune responses during infections.
How does this study contribute to infection treatment strategies?
By understanding the immune response dynamics, researchers can develop more effective treatment approaches for bacterial infections.
What are the advantages of real-time monitoring in this research?
Real-time monitoring enables longitudinal assessment of immune responses and bacterial burden, offering a comprehensive view of infection progression.
What role do neutrophils play in the immune response?
Neutrophils are key players in the innate immune response, acting as the first line of defense against infections.
What is Staphylococcus aureus?
Staphylococcus aureus is a common bacterium that can cause a range of infections, from minor skin infections to more serious conditions.
How can this research impact future studies?
The findings can inform future research on immune responses and the development of new therapeutic strategies against bacterial infections.
Executive Industry Relevance
This method enables real-time, longitudinal monitoring of neutrophil recruitment and bacterial burden in a live host, providing mechanistic insights into host-pathogen dynamics during Staphylococcus aureus infection. By quantifying innate immune responses noninvasively, it supports target validation and de-risking of immunomodulatory therapeutics in preclinical discovery. The approach enhances predictive confidence in early-stage screening by linking immune activity to infection outcomes.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by visualizing neutrophil dynamics in response to S. aureus infection.
- Operational Value: Enables functional target validation through longitudinal tracking of immune cell infiltration.
- Predictive Value: Supports portfolio triage by correlating neutrophil trafficking with disease severity and mortality outcomes.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream immunomodulator screening using dual-modality imaging.
- Operational Value: Standardizes assay readouts via quantifiable fluorescence and bioluminescence signals over time.
- Scalability Value: Facilitates platform reuse for longitudinal compound evaluation in infection models.
Translational & Preclinical Research
- Scientific Value: Examines disease-relevant immune responses in immunodeficient models to assess persistent infection and therapeutic rescue.
- Operational Value: Ensures continuity from discovery through preclinical validation by monitoring wound healing and bacterial dissemination.
- Risk Mitigation: Informs risk-adjusted advancement decisions by identifying mechanistic defects in innate immunity.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from Early Discovery to Lead Identification and Preclinical validation by enabling hypothesis testing, pathway clarification, and biological de-risking of immunomodulatory candidates.
- Discovery Biology: Supports hypothesis testing and pathway clarification by linking neutrophil recruitment to infection control.
- Screening: Delivers assay readiness through reproducible, quantitative outputs of immune and bacterial signals.
- Analytics: Provides longitudinal measurements of mean flux and wound area to compare experimental conditions.
- Translational Research: Connects to preclinical continuity via monitoring of bacterial burden and wound healing in immunocompromised hosts.
- Enterprise Reuse: Functions as a reusable imaging platform for longitudinal infection and immune response studies.
Operational & Enterprise Impact
- Scientific Value: Delivers predictive confidence by reducing mechanistic ambiguity in innate immune responses to infection.
- Operational Value: Ensures standardization and reproducibility through synchronized fluorescence and bioluminescence imaging.
- Strategic Value: Improves go/no-go decisions by linking immune dynamics to survival and weight loss outcomes.
- Portfolio Impact: Enables risk-adjusted prioritization based on neutrophil trafficking defects and bacterial persistence.
Implementation Considerations
- Requires expertise in murine infection models, surgical wounding, and anaerobic bacterial handling.
- Depends on imaging infrastructure capable of simultaneous fluorescence and bioluminescence detection.
- Necessitates cross-team standardization for consistent region-of-interest placement and signal quantification.
- Involves adaptation considerations when extending to other pathogen strains or immunocompromised models.
- Limited by mouse species-specific differences in virulence factor sensitivity compared to human infection.
Biopharma FAQs
Why does neutrophil trafficking measurement matter for target validation in S. aureus infection models?
Quantifying neutrophil emigration via LysM-EGFP fluorescence enables objective assessment of innate immune activation, which correlates with infection control and survival outcomes in the model.
How does isolating the independent variable of bacterial inoculum fit the discovery pipeline for immunomodulator screening?
Standardizing bioluminescent S. aureus inoculation ensures consistent infection initiation, allowing immune response variables to be isolated and evaluated in screening campaigns.
What do quantitative dependent variable measurements of bioluminescent and fluorescent signals enable in preclinical assessment?
Dual-modality readouts allow simultaneous tracking of bacterial burden and neutrophil dynamics, providing mechanistic insight into therapeutic effects on host-pathogen interactions.
Why do replication requirements matter for cross-functional collaboration in longitudinal infection studies?
Reproducible longitudinal imaging across cohorts ensures data consistency between discovery, screening, and translational teams evaluating immunomodulatory candidates.
What statistical analysis capabilities are required before implementing longitudinal imaging of neutrophil and bacterial signals?
The ability to plot mean flux and wound area over time enables comparison of infection trajectories and immune response kinetics across experimental groups.
Chapters in this video
0:04
Title
0:38
Bacterial Preparation and Quantification
2:44
Excisional Skin Wounding
3:50
Staphylococcus aureus Inoculation
4:44
In Vivo Bioluminescent and Fluorescence Imaging
6:02
Bioluminescent and Fluorescence Image Analysis
6:45
Results: LysM-EGFPMyD88-/- Mice are More Susceptible to S. aureus Infection Than LysM-EGFP Mice
8:30
Conclusion
